A correspondence on efficacy and safety of stem cell therapy in patients with dilated cardiomyopathy

被引:0
|
作者
Zhang, Leisheng [1 ,4 ]
Yang, Hongju [3 ]
Li, Jing [2 ]
机构
[1] Shandong First Med Univ, Peoples Hosp Jinan 4, Teaching Hosp, Sci & Technol Innovat Ctr, Jinan, Peoples R China
[2] Shandong First Med Univ, Peoples Hosp Jinan City 4, Teaching Hosp, Dept Oncol, Jinan, Peoples R China
[3] Kunming Med Univ, Affiliated Hosp 1, Geriatr Med Ctr, Div Geriatr Gastroenterol, Kunming, Peoples R China
[4] Gansu Prov Hosp, Natl Hlth Commiss NHC, Key Lab Diag & Therapy Gastrointestinal Tumor, Lanzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1097/JS9.0000000000001743
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:5989 / 5990
页数:2
相关论文
共 50 条
  • [41] Follow-up of the patients after stem cell transplantation for pediatric dilated cardiomyopathy
    Bergmane, Inta
    Lacis, Aris
    Lubaua, Inguna
    Jakobsons, Eriks
    Erglis, Andrejs
    PEDIATRIC TRANSPLANTATION, 2013, 17 (03) : 266 - 270
  • [42] THERAPY OF DILATED CARDIOMYOPATHY
    HESS, OM
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 111 (06) : 222 - 225
  • [43] Phenotype of Super-Responders to Stem Cell Therapy for Non-Ischemic Dilated Cardiomyopathy
    Rieger, Angela Castellanos
    Florea, Victoria
    Tompkins, Bryon A.
    Natsumeda, Makoto
    Landin, Ana Marie
    Premer, Courtney
    Schulman, Ivonne H.
    Hare, Joshua M.
    JOURNAL OF CARDIAC FAILURE, 2017, 23 (08) : S90 - S90
  • [44] INTRACORONARY AUTOLOGOUS PERIPHERAL STEM CELL THERAPY FOR PEDIATRIC DILATED CARDIOMYOPATHY: BRIDGE TO TRANSPLANTATION OR TO RECOVERY?
    Tejerina, T.
    Menendez, J. J.
    Gonzalez Rocafort, A.
    Redondo, S.
    Rivas, J.
    Garcia-Guereta, L.
    Arrieta, R.
    Romero, M. P.
    Alves, J.
    Gutierrez-Larraya, F.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 17 - 17
  • [45] Phenotype of Super-Responders to Stem Cell Therapy for Non-Ischemic Dilated Cardiomyopathy
    Rieger, Angela C.
    Florea, Victoria
    Tompkins, Bryon A.
    Natsumeda, Makoto
    Landin, Ana M.
    Premer, Courtney
    Schulman, Ivonne H.
    Hare, Joshua M.
    CIRCULATION, 2017, 136
  • [46] Safety and efficacy of stem cell mobilization under imatinib therapy
    Kreuzer, CA
    Klühs, C
    Schwarz, M
    Dörken, B
    le Coutre, P
    HAEMATOLOGICA, 2003, 88 (10) : 1199 - 1200
  • [47] Rosuvastatin in dilated cardiomyopathy: a double blind, randomised trial of efficacy and safety
    Broch, K.
    Askevold, E. T.
    Gjertsen, E.
    Mo, R.
    Stueflotten, W.
    Andreassen, J.
    Svendsmark, R.
    Aakhus, S.
    Aukrust, P.
    Gullestad, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S284 - S284
  • [48] Cell therapy in dilated chagasic cardiomyopathy: the MiHeart study
    Feitosa, G.
    Ribeiro Dos Santos, R.
    Rassi, S.
    Grecco, O.
    Rassi, A.
    Cunha, A. B.
    Carvalho, V.
    Guarita Souza, L. C.
    Soares, M.
    Campos De Carvalho, A. C.
    EUROPEAN HEART JOURNAL, 2010, 31 : 323 - 324
  • [49] Transplantation of allogenic cells in the therapy of patients with dilated cardiomyopathy
    Kirillov, A. M.
    Fatkhudinov, T. Kh.
    Dyachkov, A. V.
    Koroteev, A. V.
    Goldshtein, D. V.
    Bochkov, N. P.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 144 (04) : 635 - 639
  • [50] Possibilities of Testosterone in Complex Therapy of Patients With Dilated Cardiomyopathy
    Kurbanov, R. D.
    Abdullaev, T. A.
    Mardanov, B. U.
    KARDIOLOGIYA, 2009, 49 (12) : 50 - 50